Clarity Pharmaceuticals Ltd.ASX: CU6

Phase II SABRE prostate cancer trial reaches 50% recruitment

Jul 24, 2023 at 2:46 AM UTC · Issued by Clarity Pharmaceuticals Ltd.

Clarity Pharmaceuticals Ltd has released a press release.

View Attachment